Similar articles for PMID: 22149736

Year	Number of Results
1997	1
1998	1
1999	1
2000	2
2001	6
2002	2
2003	4
2004	4
2005	8
2006	5
2007	14
2008	10
2009	14
2010	6
2011	12
2012	10
2013	6
2014	3
2015	1
2017	1
2018	1
2021	3
2022	3
2023	1
2024	0

1

Generic atorvastatin and health care costs.

Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM. Jackevicius CA, et al. N Engl J Med. 2012 Jan 19;366(3):201-4. doi: 10.1056/NEJMp1113112. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149736 Free PMC article. No abstract available.

2

Generic atorvastatin and health care costs.

Kennally WC 3rd. Kennally WC 3rd. N Engl J Med. 2012 Apr 12;366(15):1451; author reply 1451. doi: 10.1056/NEJMc1202104. N Engl J Med. 2012. PMID: 22494136 No abstract available.

3

Cholesterol drugs: Lipitor battles generics.

[No authors listed] [No authors listed] Consum Rep. 2008 Mar;73(3):48-9. Consum Rep. 2008. PMID: 18655329 No abstract available.

4

Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.

Mullins CD, Rattinger GB, Kuznik A, Koren MJ. Mullins CD, et al. Clin Ther. 2008;30 Pt 2:2204-16. doi: 10.1016/j.clinthera.2008.12.007. Clin Ther. 2008. PMID: 19281915

5

What price atorvastatin?

[No authors listed] [No authors listed] Drug Ther Bull. 2012 Jul;50(7):73. doi: 10.1136/dtb.2012.05.0113. Epub 2012 Jul 4. Drug Ther Bull. 2012. PMID: 22764068 No abstract available.

6

Is initiation of atorvastatin for employees a good buy for employers?

Culler SD, Weintraub WS. Culler SD, et al. Mayo Clin Proc. 2009 Dec;84(12):1059-61. doi: 10.4065/mcp.2009.0630. Mayo Clin Proc. 2009. PMID: 19955241 Free PMC article. No abstract available.

7

Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population.

Annemans L, Marbaix S, Webb K, Van Gaal L, Scheen A. Annemans L, et al. Clin Drug Investig. 2010;30(2):133-42. doi: 10.2165/11531910-000000000-00000. Clin Drug Investig. 2010. PMID: 20067331

8

Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain.

Barrios V, Lobos JM, Serrano A, Brosa M, Capel M, Alvarez Sanz C. Barrios V, et al. J Med Econ. 2012;15 Suppl 1:45-54. doi: 10.3111/13696998.2012.726674. Epub 2012 Sep 12. J Med Econ. 2012. PMID: 22954062 Free article.

9

Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapy.

Simoens S, Sinnaeve PR. Simoens S, et al. Cardiovasc Drugs Ther. 2013 Feb;27(1):49-60. doi: 10.1007/s10557-012-6432-y. Cardiovasc Drugs Ther. 2013. PMID: 23242669 Review.

10

[Lean years for patients].

Klose G, Anlauf M. Klose G, et al. MMW Fortschr Med. 2004 Dec 16;146(51-52):16. MMW Fortschr Med. 2004. PMID: 15675237 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

114 results

Results by year